hVIVO PLC. Stock Analysis HVO.L

hVIVO PLC is a contract research organization. The firm delivers end-to-end clinical development services to a diverse and expanding client base. The company specializes in conducting human challenge trials across multiple infectious and respiratory indications, leveraging its quarantine facility. The firm also offers comprehensive virology and immunology laboratory services under the hLAB brand. The Company, through its subsidiary, operates an approximately 120-bed capacity across Mannheim and Kiel, providing early-phase clinical trial services, including first-in-human and proof-of-concept studies. The company also offers Early Drug Development Consulting and Biometry services to the biopharma sector. The firm also provides industry-standard, temperature-controlled storage solutions for biological and clinical materials.